Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
SWOG Cancer Research Network
University Hospital, Clermont-Ferrand
National Institutes of Health Clinical Center (CC)
University College Cork
Kaiser Permanente
AstraZeneca
Context Therapeutics Inc.
Indiana University
University of Arizona
BioNTech SE
Indiana University
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Loma Linda University
City of Hope Medical Center
University of Nebraska
Swiss Cancer Institute
Vastra Gotaland Region
Cantonal Hospital of St. Gallen
Ordu University
University of Southern California